Jane Street
TVTX icon

Jane Street’s Travere Therapeutics TVTX Stock Holding History

Jane Street’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.44M Buy
48,500
+7,400
+18% +$221K ﹤0.01% 5727
2025
Q4 		$1.57M Sell
41,100
-27,800
-40% -$904K ﹤0.01% 5258
2025
Q3 		$1.65M Buy
+68,900
New +$1.3M ﹤0.01% 5298
2025
Q2 		– Sell
-413,700
Closed -$7.41M – 10930
2025
Q1 		$7.41M Sell
413,700
-132,900
-24% -$2.7M ﹤0.01% 2372
2024
Q4 		$9.52M Sell
546,600
-7,100
-1% -$126K ﹤0.01% 1931
2024
Q3 		$7.75M Buy
553,700
+369,600
+201% +$3.85M ﹤0.01% 2219
2024
Q2 		$1.51M Sell
184,100
-159,100
-46% -$1.07M ﹤0.01% 4988
2024
Q1 		$2.65M Buy
343,200
+15,500
+5% +$131K ﹤0.01% 3620
2023
Q4 		$2.95M Buy
327,700
+257,800
+369% +$1.88M ﹤0.01% 3668
2023
Q3 		$625K Buy
69,900
+32,300
+86% +$456K ﹤0.01% 5930
2023
Q2 		$578K Buy
+37,600
New +$684K ﹤0.01% 6100
2022
Q2 		– Sell
-9,100
Closed -$235K – 10914
2022
Q1 		$235K Buy
9,100
+2,600
+40% +$69K ﹤0.01% 8792
2021
Q4 		$202K Buy
+6,500
New +$183K ﹤0.01% 8809
2021
Q3 		– Sell
-13,800
Closed -$201K – 10751
2021
Q2 		$201K Buy
+13,800
New +$272K ﹤0.01% 8818
2019
Q4 		– Sell
-10,400
Closed -$121K – 5767
2019
Q3 		$121K Buy
+10,400
New +$172K ﹤0.01% 4766
2015
Q3 		– Sell
-17,900
Closed -$593K – 4160
2015
Q2 		$593K Buy
+17,900
New +$490K ﹤0.01% 2110

Other funds holding TVTX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jane Street's TVTX Position: Q1 2026 in Review

Jane Street reduced its Travere Therapeutics (TVTX) stake by 23% in Q1 2026, selling an estimated $2.69M and leaving 302,280 shares worth $8.98M. The position accounts for ﹤0.01% of the portfolio, ranked #2670.

Jane Street first reported a position in TVTX in Q1 2014 and has held it in 25 quarters since. The position peaked at $15M in Q4 2025. 260 funds tracked by Wall St. Rank hold TVTX as of Q1 2026.

  • Jane Street held 302,280 shares of Travere Therapeutics worth $8.98M as of Q1 2026.
  • Jane Street sold 89,993 Travere Therapeutics shares in Q1 2026, an estimated $2.69M.
  • Travere Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #2670 holding.
  • Jane Street first reported a position in Travere Therapeutics in Q1 2014 and has held it in 25 quarters since.
  • Jane Street's Travere Therapeutics position peaked at $15M in Q4 2025.
  • 260 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.